Study on the Characteristics of Non-targeted Metabolomics and EEG of Delayed Neurocognitive Recovery in Elderly Patients
1 other identifier
observational
80
1 country
1
Brief Summary
Perioperative neurocognitive disorder (PND) refers to a broad range of postoperative cognitive complications, including preoperatively diagnosed cognitive decline, postoperative delirium (POD), delayed neurocognitive recovery (dNCR), and neurocognitive disorders . Among them, dNCR refers to a decline in cognitive function that occurs approximately 1-4 weeks after anesthesia/surgery in elderly patients. It is associated with an increased risk of postoperative complications and an increased length of hospital stay. The identification of potential predictive biomarkers would be beneficial for determining the individual risk of developing dNCR and for postoperative management of elderly patients. Although some predictive markers for PNDs, such as inflammatory factors, tau protein, S100B protein, neuron-specific enolase, and brain-derived neurotrophic factor, are widely known, most of them are postoperative predictive markers. The markers that can be used to predict PNDs before anesthesia/surgery are still largely unknown. Preoperative markers allow us to identify individuals who are susceptible to dNCR and intervene early. It is unclear whether the metabolic status of preoperative patients is related to the occurrence of postoperative cognitive dysfunction (POCD). In the framework of systems biology based on genome, transcriptome, proteome, and metabolome, metabolomics is the closest to biological phenotypes because it reflects biological events that have occurred in living organisms. Considering that metabolome reflects the metabolites of all biochemical reactions that have already taken place in an organism and contains a huge amount of information about an organism's health, preoperative patient metabolites may be a useful predictive biomarker. In this study, we used serum metabolomics to develop non-invasive, easily detectable, and inexpensive preoperative biomarkers from patient blood to determine the individual risk of dNCR and the relationship between metabolic system abnormalities and the pathogenesis of dNCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2021
CompletedFirst Submitted
Initial submission to the registry
May 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
July 18, 2023
July 1, 2023
5.6 years
May 28, 2021
July 16, 2023
Conditions
Outcome Measures
Primary Outcomes (10)
MMSE (mini-mental state examiniation)
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
1 day after surgery
MOCA (Montreal Cognitive Assessment)
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
1 day after surgery
MMSE (mini-mental state examiniation)
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
3 day after surgery
MOCA (Montreal Cognitive Assessment)
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
3 day after surgery
MMSE (mini-mental state examiniation)
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR. a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
7 day after surgery
MOCA (Montreal Cognitive Assessment)
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
7 day after surgery
MOCA (Montreal Cognitive Assessment)
MOCA sacle score,baseline
right before surgery
MMSE (mini-mental state examiniation)
MMSE scale score, baseline
right before surgery
T-MoCA (The telephone MoCA)
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
15 day after surgery
T-MoCA (The telephone MoCA)
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
30 day after surgery
Secondary Outcomes (3)
3D-CAM
1 day after surgery
Self-Rating Anxiety Scale
right before surgery
Self-rating depression scale
right before surgery
Study Arms (2)
Patients in the control group were followed up without dNCR postoperatively.
If the MOCA or MMSE assessment all show a negative resluts at all time point.
Patients in the case group were followed up with dNCR postoperatively.
If the MOCA assessment is positive at any time point after surgery, and there is a positive MMSE at any time point after surgery(no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
Interventions
Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),arterial blood gas data(before induction of anesthesia and first day after surgery) and venous blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)
Eligibility Criteria
Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients over 65 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and dNCR. scales were evaluated.
You may qualify if:
- Gender: no gender limit
- years or older .
- Complete the operation in our hospital
- ASA classification I-II level
- Agree to participate in this research and agree to sign an informed consent form
You may not qualify if:
- History of preoperative psychosis and psychotropic drug use
- The subject is diagnosed with AD;
- Abnormal preoperative mental scale assessment
- Have a history of emergency rescue during the perioperative period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai 9Th Hospital
Shanghai, Shanghai Municipality, 200000, China
Related Publications (2)
Zhang L, Liu J, Zhou R, Liu J, Zhang J, Mao H, Yan J, Jiang H. Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals. Clin Nutr ESPEN. 2025 Aug;68:727-736. doi: 10.1016/j.clnesp.2025.06.016. Epub 2025 Jun 13.
PMID: 40518008DERIVEDMao H, Huang H, Zhou R, Zhu J, Yan J, Jiang H, Zhang L. High preoperative blood oxaloacetate and 2-aminoadipic acid levels are associated with postoperative delayed neurocognitive recovery. Front Endocrinol (Lausanne). 2023 Jul 31;14:1212815. doi: 10.3389/fendo.2023.1212815. eCollection 2023.
PMID: 37583434DERIVED
Biospecimen
whole blood
Study Officials
- STUDY DIRECTOR
Hong Jiang, Doctor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2021
First Posted
November 3, 2021
Study Start
May 22, 2021
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
July 18, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share